BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12441266)

  • 1. Cell division cycle control in embryonal and alveolar rhabdomyosarcomas.
    Moretti A; Borriello A; Monno F; Criscuolo M; Rosolen A; Esposito G; Dello Iacovo R; Della Ragione F; Iolascon A
    Eur J Cancer; 2002 Nov; 38(17):2290-9. PubMed ID: 12441266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
    Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
    Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
    Ponzio G; Loubat A; Rochet N; Turchi L; Rezzonico R; Farahi Far D; Dulic V; Rossi B
    Oncogene; 1998 Sep; 17(9):1159-66. PubMed ID: 9764826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
    Green SL; Freiberg RA; Giaccia AJ
    Mol Cell Biol; 2001 Feb; 21(4):1196-206. PubMed ID: 11158306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).
    Perez-Roger I; Kim SH; Griffiths B; Sewing A; Land H
    EMBO J; 1999 Oct; 18(19):5310-20. PubMed ID: 10508164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
    Bhatia N; Agarwal C; Agarwal R
    Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation.
    Furukawa Y; Kikuchi J; Nakamura M; Iwase S; Yamada H; Matsuda M
    Br J Haematol; 2000 Sep; 110(3):663-73. PubMed ID: 10997979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
    J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density growth arrest in Ras-transformed cells: low Cdk kinase activities in spite of absence of p27(Kip) Cdk-complexes.
    Groth A; Willumsen BM
    Cell Signal; 2005 Sep; 17(9):1063-73. PubMed ID: 15993748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
    Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
    Hupfeld CJ; Weiss RH
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.